NACB - Scientific Shorts
NACB - Scientific Shorts (formerly NACB Blog)
By Dr. Wendy Alderton, Chief Scientific Officer, Abcodia Ltd, UK
PermalinkRecommendFacebookEmailComments
Over recent decades good progress has been made in survival for many types of cancer, including breast, colorectal, testicular, and prostate cancers. But some types of malignancies, including pancreatic cancer, have remained resistant to efforts to improve outcomes. Pancreatic cancer has a 5 year r...(Read More)
By Xuan Mu, PhD
PermalinkRecommendFacebookEmailComments
Cystic Fibrosis (CF) is one of the most common inherited disorders, primarily caused by mutations of a single gene, CF transmembrane conductance regulator (CFTR). An estimated 1.2 million individuals are tested for CF every year in the US (1). Over 127 mutations are associated with the pathogenesis...(Read More)
By Danyel Tacker
PermalinkRecommendFacebookEmailComments
​Part I: Case Presentation A male in his late teens, lean and non-diabetic, was brought to the Emergency Department by his parents. Over the last several hours, he displayed increasing confusion and lethargy. At the time of presentation, he was stuporous and his function declining. Liver function ...(Read More)
By Angela M. Ferguson, Ph.D., DABCC, FACB
PermalinkRecommendFacebookEmailComments
Clinical Impact of the BuBc Slide RecalibOrtho Clinical Diagnostics’ method of measuring bilirubin is unique when compared to other commonly used methods.  The difference between the methods is the way different bilirubin fractions are measured or calculated.  Total bilirubin is measured with the T...(Read More)
1 - 4 Next